Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 789,839 | 647,263 | 536,880 | 571,644 | 624,428 |
| Cost of Goods | 329,619 | 279,952 | 243,892 | 254,276 | 293,989 |
| Gross Profit | 460,220 | 367,311 | 292,988 | 317,368 | 330,439 |
| Operating Expenses | 275,228 | 258,663 | 242,138 | 243,271 | 272,223 |
| Operating Income | 185,611 | 109,600 | 51,742 | 74,373 | 59,205 |
| Interest Expense | 4,703 | 5,728 | 5,740 | 5,690 | 6,064 |
| Other Income | 907,994 | 1,580,589 | 1,199,943 | 830,016 | 646,289 |
| Pre-tax Income | 1,088,902 | 1,684,461 | 1,245,945 | 898,699 | 699,430 |
| Income Tax | 241,838 | 369,637 | 279,516 | 212,787 | 145,944 |
| Net Income Continuous | 847,064 | 1,314,824 | 966,429 | 685,912 | 553,486 |
| Net Income | $847,064 | $1,314,824 | $966,429 | $685,912 | $553,486 |
| EPS Basic Total Ops | 28.33 | 44.24 | 32.59 | 22.97 | 18.50 |
| EPS Basic Continuous Ops | 28.33 | 44.24 | 32.59 | 22.97 | 18.49 |
| EPS Diluted Total Ops | 27.96 | 43.64 | 32.15 | 22.72 | 18.35 |
| EPS Diluted Continuous Ops | 27.96 | 43.64 | 32.15 | 22.72 | 18.34 |
| EBITDA(a) | $185,611 | $109,600 | $51,742 | $74,373 | $59,205 |